Alpha-adrenergic blocking agents in the treatment of asthma.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D006801:Humans; D007217:Indoramin / Q000627:therapeutic use; D013948:Moxisylyte / Q000627:therapeutic use; D010646:Phentolamine / Q000627:therapeutic use; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects
D000317:Adrenergic alpha-Antagonists; D011942:Receptors, Adrenergic, alpha; D007217:Indoramin; D013948:Moxisylyte; D010646:Phentolamine